These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3111783

  • 61. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [Abstract] [Full Text] [Related]

  • 62. Norplant contraceptive subdermal implants: one year experience in Singapore.
    Singh K, Viegas OA, Ratnam SS.
    Contraception; 1988 May; 37(5):457-69. PubMed ID: 3136971
    [Abstract] [Full Text] [Related]

  • 63. Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
    Ratsula K.
    Contraception; 1987 Dec; 36(6):659-66. PubMed ID: 3128429
    [Abstract] [Full Text] [Related]

  • 64. The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation.
    Souka AR, el Sokkary H, Kamel M, Hassan M.
    Contraception; 1986 Apr; 33(4):365-71. PubMed ID: 3731776
    [Abstract] [Full Text] [Related]

  • 65. A subdermal progestin implant for long-term contraception.
    Med Lett Drugs Ther; 1991 Mar 08; 33(839):17-8. PubMed ID: 1899898
    [Abstract] [Full Text] [Related]

  • 66. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR, Morehead DB, Baldwin DM, Castracane VD, Lasley B, Bergquist CA.
    Fertil Steril; 1996 Jul 08; 66(1):43-8. PubMed ID: 8752609
    [Abstract] [Full Text] [Related]

  • 67. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
    Goodger AM, Rogers PA, Affandi B.
    Hum Reprod; 1994 Sep 08; 9(9):1647-51. PubMed ID: 7530724
    [Abstract] [Full Text] [Related]

  • 68. Subdermal progestin implant contraception.
    Darney PD.
    Curr Opin Obstet Gynecol; 1991 Aug 08; 3(4):470-6. PubMed ID: 1908716
    [Abstract] [Full Text] [Related]

  • 69. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
    Faundes A, Alvarez F, Brache V, Tejada AS.
    Int J Gynaecol Obstet; 1988 Jun 08; 26(3):429-33. PubMed ID: 2900174
    [Abstract] [Full Text] [Related]

  • 70. Corpus luteum function in subdermal levonorgestrel implant users.
    Ibrahim II, Abdalla MI, Osman MI, Hassanein AA, Toppozada MH, Abdelaal AE, Hafez ES.
    Contracept Deliv Syst; 1983 Sep 08; 4(4):317-21. PubMed ID: 12265808
    [Abstract] [Full Text] [Related]

  • 71. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
    Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H.
    Fertil Steril; 1998 Apr 08; 69(4):714-21. PubMed ID: 9548163
    [Abstract] [Full Text] [Related]

  • 72. Norplant-2 rods: one year experience in Singapore.
    Singh K, Viegas OA, Liew D, Singh P, Ratnam SS.
    Contraception; 1988 Oct 08; 38(4):429-40. PubMed ID: 3145168
    [Abstract] [Full Text] [Related]

  • 73. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    Luukkainen T, Allonen H, Haukkamaa M, Holma P, Pyörälä T, Terho J, Toivonen J, Batar I, Lampe L, Andersson K.
    Contraception; 1987 Aug 08; 36(2):169-79. PubMed ID: 3123132
    [Abstract] [Full Text] [Related]

  • 74. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM, Witjaksono J, Affandi B, Rogers PA.
    Hum Reprod; 1996 Dec 08; 11(12):2629-34. PubMed ID: 9021364
    [Abstract] [Full Text] [Related]

  • 75. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS.
    J SOGC; 1993 Oct 08; 15(8):925-8, 32. PubMed ID: 12318530
    [Abstract] [Full Text] [Related]

  • 76. Androgen levels in women using Norplant implants.
    Olsson SE, Odlind V, Johansson E.
    Contraception; 1986 Aug 08; 34(2):157-67. PubMed ID: 2946553
    [Abstract] [Full Text] [Related]

  • 77. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V, Moo-Young AJ, Gupta GN, Weiner E, Johansson ED.
    Contraception; 1979 Jun 08; 19(6):639-48. PubMed ID: 487813
    [Abstract] [Full Text] [Related]

  • 78. Serum nickel, copper and zinc in Norplant users.
    Ismail AA, Toppozada M, Zahran M, Ghanem I, Kholeif A.
    Contraception; 1992 Jun 08; 45(6):561-72. PubMed ID: 1617965
    [Abstract] [Full Text] [Related]

  • 79. IMAP statement on Norplant subdermal contraceptive implant system.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP.
    IPPF Med Bull; 1993 Apr 08; 27(2):1-3. PubMed ID: 12345306
    [Abstract] [Full Text] [Related]

  • 80. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
    Roy S, Mishell DR, Robertson DN, Krauss RM, Lacarra M, Duda MJ.
    Am J Obstet Gynecol; 1984 Apr 01; 148(7):1006-13. PubMed ID: 6424474
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.